| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 83.71B | 158.13B | 85.06B | 85.96B | 77.98B | 76.84B |
| Gross Profit | 71.69B | 135.85B | 69.57B | 74.18B | 70.83B | 65.35B |
| EBITDA | 16.05B | 23.02B | 11.64B | 12.86B | 18.75B | 20.28B |
| Net Income | 11.44B | 12.63B | 8.12B | 9.05B | 8.74B | 9.39B |
Balance Sheet | ||||||
| Total Assets | 6.23T | 6.54T | 6.39T | 5.76T | 5.60T | 5.71T |
| Cash, Cash Equivalents and Short-Term Investments | 0.00 | 1.39T | 1.65T | 1.58T | 1.35T | 1.61T |
| Total Debt | 26.27B | 1.39T | 585.99B | 448.86B | 578.87B | 794.96B |
| Total Liabilities | 5.99T | 6.28T | 6.17T | 5.51T | 5.37T | 5.45T |
| Stockholders Equity | 234.95B | 244.55B | 212.02B | 244.22B | 229.64B | 256.56B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | -17.29B | 0.00 | 0.00 | -134.00B | 288.90B |
| Operating Cash Flow | 0.00 | -6.78B | 0.00 | 0.00 | -128.95B | 294.12B |
| Investing Cash Flow | 0.00 | -371.60B | -412.50B | 51.41B | -117.36B | -149.14B |
| Financing Cash Flow | 0.00 | 104.18B | 199.38B | 306.37B | -10.42B | -5.70B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
71 Outperform | ¥251.56B | 14.45 | ― | 2.13% | 11.80% | -4.44% | |
70 Outperform | ¥238.37B | 8.55 | ― | 3.00% | 15.17% | 21.00% | |
68 Neutral | $18.00B | 11.42 | 9.92% | 3.81% | 9.73% | 1.22% | |
65 Neutral | ¥244.84B | 8.20 | ― | 3.46% | 9.73% | 15.55% | |
65 Neutral | ¥245.85B | 10.90 | ― | 2.53% | 11.64% | 28.24% | |
59 Neutral | ¥270.90B | 10.68 | ― | 2.55% | 8.16% | 35.67% | |
55 Neutral | ¥212.77B | 8.99 | ― | 2.38% | 33.44% | 57.44% |